Astria Therapeutics, Inc.

Q3 2022 13F Holders

Symbol
ATXS
CUSIP
04635X102
Type
Equity
Class
COM
Num filings
44
Total reported value, excl. options
$88.8 M
Manager Report Date Value ($000) Shares Option Type